I
Ismail Elalamy
Researcher at I.M. Sechenov First Moscow State Medical University
Publications - 11
Citations - 552
Ismail Elalamy is an academic researcher from I.M. Sechenov First Moscow State Medical University. The author has contributed to research in topics: Septic shock & Disseminated intravascular coagulation. The author has an hindex of 4, co-authored 11 publications receiving 299 citations. Previous affiliations of Ismail Elalamy include Institut Universitaire de France.
Papers
More filters
Journal ArticleDOI
Measuring Oral Direct Inhibitors (ODIs) of thrombin and factor Xa: A recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.
TL;DR: Oral direct inhibitors of thrombin and factor Xa are now approved as anticoagulant drugs as pharmacokinetic and pharmacodynamic responses are reliably predicted in patients with adequate renal function who are not taking other interacting drugs.
Journal ArticleDOI
Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis.
Stavros K. Kakkos,Manjit Gohel,Niels Bækgaard,Rupert Bauersachs,Sergi Bellmunt-Montoya,Stephen A. Black,Stephen A. Black,Arina J. ten Cate-Hoek,Ismail Elalamy,Florian K. Enzmann,George Geroulakos,Anders Gottsäter,Beverley J. Hunt,Armando Mansilha,Andrew N. Nicolaides,Andrew N. Nicolaides,Per Morten Sandset,Gerard Stansby,Gerard Stansby,Gert J. de Borst,Frederico Bastos Gonçalves,Nabil Chakfe,Robert J. Hinchliffe,Philippe Kolh,Igor Koncar,Jes S. Lindholt,Riikka Tulamo,Christopher P. Twine,Frank Vermassen,Anders Wanhainen,Marianne G. De Maeseneer,Anthony J. Comerota,Peter Gloviczki,Marieke J. H. A. Kruip,Manuel Monreal,Paolo Prandoni,Melina Vega de Ceniga +36 more
TL;DR: The European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis as discussed by the authors have been published for the management of venous thrombotic vessels.
Journal ArticleDOI
SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia.
Ismail Elalamy,Ismail Elalamy,Grigoris T. Gerotziafas,Sonia Alamowitch,Jean-Pierre Laroche,Patrick Van Dreden,Walter Ageno,Jan Beyer-Westendorf,Alexander T. Cohen,David Jiménez,Benjamin Brenner,Benjamin Brenner,Saskia Middeldorp,Patrice Cacoub,Patrice Cacoub +14 more
TL;DR: In this paper, a panel of experts express their insights and propose a tracking algorithm for vaccinated patients based on a 10-point guideline for decision-making on what to do and not to do.
Journal ArticleDOI
Thrombotic microangiopathy in cancer patients
Alexander Makatsariya,Макацария Александр Давидович,Ismail Elalamy,Элалами Исмаил,A. V. Vorobev,Воробьев Александр Викторович,Angelina S. Bakhtina,Бахтина Ангелина Сергеевна,Muyang Meng,Мэн Муян,Victoria Bitsadze,Бицадзе Виктория Омаровна,Jamilya Khizroeva,Хизроева Джамиля Хизриевна +13 more
TL;DR: The review presents a modern data on the pathogenesis of tumor-associated thrombotic microangiopathy, and considers the interaction of various effectors related to both tumor growth and metastasis process ― immune system activation, endotheliopathy formation, use of chemotherapeutic agents and targeted therapy in the pathogenic of various forms of TMA.
Iconographies supplémentaires de l'article : Risque thromboembolique en oncologie : réalités, actualités et perspectives
TL;DR: The current status of knowledge on the connection between cancer and hypercoagulability, the numerous risk factors for VTE must be identified in cancer patients and the best methodology to build a more accurate assessment of this vascular risk in such a complex medical context are reported.